Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

por Doi, T, Takiuchi, H, Ohtsu, A, Fuse, N, Goto, M, Yoshida, M, Dote, N, Kuze, Y, Jinno, F, Fujimoto, M, Takubo, T, Nakayama, N, Tsutsumi, R
Publicado 2012

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

por Yamaguchi, K, Shimamura, T, Hyodo, I, Koizumi, W, Doi, T, Narahara, H, Komatsu, Y, Kato, T, Saitoh, S, Akiya, T, Munakata, M, Miyata, Y, Maeda, Y, Takiuchi, H, Nakano, S, Esaki, T, Kinjo, F, Sakata, Y
Publicado 2006

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

por Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Publicado 2012